Clinical trials
Phase 2/3 Cytokine Release Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 6 |
| 2021 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 3 |
| Completed | 2 |
| Terminated | 2 |
| Withdrawn | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Colorado, Denver | 2 |
| Dermama Bioteknologi Laboratorium | 1 |
| Hamad Medical Corporation | 1 |
| Health Institutes of Turkey | 1 |
| Inmune Bio, Inc. | 1 |
| Instituto Venezolano de Investigaciones Cientificas | 1 |
| Karolinska Institutet | 1 |
| King Saud University | 1 |
| Tehran University of Medical Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cytokine Release Syndrome | 10 |
| COVID-19 | 9 |
| Inflammation | 2 |
| Virus Diseases | 2 |
| Burkitt Lymphoma | 1 |
| Coronavirus Infections | 1 |
| Lymphoma, Follicular | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Pneumonia | 1 |
Trials
Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.